PERFORMANCE / SINGLE
GHRP-6 ACETATE
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A growth-hormone secretagogue studied for its interaction with the GHS-R1a receptor in performance and signalling research.
Available Strengths
- 5MG (G65)
- 10MG (G610)
Research Protocol
Reference schedule (dose shown per injection, three times daily)
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.1 mg | 6 | 0.06 mL |
| Weeks 3–4 | 0.2 mg | 12 | 0.12 mL |
| Weeks 5–12 | 0.3 mg | 18 | 0.18 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Described as binding the growth-hormone secretagogue receptor to trigger pulsatile GH release while the cited research notes physiological feedback controls remain intact.
Storage
−20°C. 2–8°C, use within 7 days, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source